Tomás H
González Hernández
Catedrático de Universidad
Tomás H González Hernández-rekin lankidetzan egindako argitalpenak (11)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism
Pharmacological Research, Vol. 165
2020
-
DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis
Autophagy, Vol. 16, Núm. 7, pp. 1279-1295
2016
-
Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system
Neurobiology of Disease, Vol. 88, pp. 44-54
2015
-
Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake
Neurobiology of Disease, Vol. 74, pp. 325-335
2014
-
Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons
Frontiers in Neuroanatomy, Vol. 8, Núm. AUG
2013
-
Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein
Histology and Histopathology, Vol. 28, Núm. 8, pp. 999-1006
2010
-
The dopamine transporter is differentially regulated after dopaminergic lesion
Neurobiology of Disease, Vol. 40, Núm. 3, pp. 518-530
-
The neuronal-specific SGK1.1 kinase regulates δ-epithelial Na + channel independently of PY motifs and couples it to phospholipase C signaling
American Journal of Physiology - Cell Physiology, Vol. 299, Núm. 4
-
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
Frontiers in Neuroanatomy
2009
-
Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508